Literature DB >> 1749229

Services for thalassaemia as a model for cost-benefit analysis of genetics services.

B Modell1, A M Kuliev.   

Abstract

Economic appraisal of genetics services is usually limited to consideration of financial costs and benefits, but this can generate misunderstandings about the aims of these services. We propose a general framework for economic analysis that includes non-financial costs and benefits, and the concept of genetic fitness.

Entities:  

Mesh：

Year:  1991        PMID： 1749229     DOI： 10.1007/bf01797934

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  11 in total

1.  An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration.

Authors:  M Gill; V Murday; J Slack
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

2.  The short-term reduction in birth incidence of recessive diseases as a result of genetic counselling after the birth of an affected child.

Authors:  G R Fraser
Journal:  Hum Hered       Date:  1972       Impact factor: 0.444

3.  Cost-benefit analysis of a thalassemia disease prevention program.

Authors:  J T Ostrowsky; A Lippman; C R Scriver
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

4.  First-trimester fetal diagnosis for haemoglobinopathies: report on 200 cases.

Authors:  J M Old; A Fitches; C Heath; S L Thein; D J Weatherall; R Warren; C McKenzie; C H Rodeck; B Modell; M Petrou
Journal:  Lancet       Date:  1986-10-04       Impact factor: 79.321

5.  Management of thalassaemia major.

Authors:  B Modell; M Petrou
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

6.  Measuring the benefits of screening for open neural tube defects.

Authors:  J B Henderson
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

7.  Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major.

Authors:  B Modell; R H Ward; D V Fairweather
Journal:  Br Med J       Date:  1980-06-07

8.  A cost-benefit analysis of prenatal detection of Down syndrome and neural tube defects in older mothers.

Authors:  A D Sadovnick; P A Baird
Journal:  Am J Med Genet       Date:  1981

9.  Preventing the birth of infants with Down's syndrome: a cost-benefit analysis.

Authors:  S Hagard; F A Carter
Journal:  Br Med J       Date:  1976-03-27

10.  Prenatal diagnosis and genetic screening. Community and service implications. Summary and recommendations of a report of the Royal College of Physicians.

Authors: 
Journal:  J R Coll Physicians Lond       Date:  1989-10
View more
  4 in total

1.  Response to: What counts as success in genetic counselling?

Authors:  Angus Clarke
Journal:  J Med Ethics       Date:  1993-03       Impact factor: 2.903

2.  Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.

Authors:  J J Mitchell; A Capua; C Clow; C R Scriver
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

3.  Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Authors:  P T Rowley; S Loader; R M Kaplan
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

4.  Preconceptional genetic carrier testing and the commercial offer directly-to-consumers.

Authors:  Pascal Borry; Lidewij Henneman; Phillis Lakeman; Leo P ten Kate; Martina C Cornel; Heidi C Howard
Journal:  Hum Reprod       Date:  2011-02-28       Impact factor: 6.918
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.